Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Investing Cash Flow
-$13.71M
TTM · Period ending: · USD
LCTX Investing Cash Flow
Latest reported-$13.71Mperiod ending
Latest reported-$13.71Mperiod ending
LCTX TTM Cash from Investing (-$100.00K → -$13.71M)
TTM investing cash flow
High-resolution chart · PNG
LCTX investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -13,712,000 | |
| -17,686,000 | |
| -13,457,000 | |
| 4,512,000 | |
| 8,412,000 | |
| -367,000 | |
| -2,308,000 | |
| 4,799,000 | |
| 3,033,000 | |
| 30,985,000 | |
| 46,449,000 | |
| 31,605,000 | |
| -11,431,000 | |
| -30,687,000 | |
| -46,159,000 | |
| -41,203,000 | |
| -357,000 | |
| -375,000 | |
| 9,745,000 | |
| 10,793,000 | |
| 11,039,000 | |
| 17,856,000 | |
| 13,038,000 | |
| 12,856,000 | |
| 26,163,000 | |
| 19,267,000 | |
| 16,957,000 | |
| 26,021,000 | |
| 12,398,000 | |
| 12,551,000 | |
| 11,816,000 | |
| 1,449,000 | |
| 6,429,000 | |
| 1,140,000 | |
| -10,225,000 | |
| -10,051,000 | |
| -15,357,000 | |
| -18,378,000 | |
| -10,889,000 | |
| -13,068,000 | |
| -14,631,000 | |
| -8,732,611 | |
| -7,441,000 | |
| -5,061,441 | |
| -3,126,909 | |
| -853,575 | |
| -1,007,804 | |
| -2,457,885 | |
| -3,582,935 | |
| -3,642,654 | |
| -3,665,587 | |
| -2,202,975 | |
| -1,037,105 | |
| -538,109 | |
| -104,687 | |
| -338,774 | |
| -529,689 | |
| -1,031,859 | |
| -1,202,713 | |
| 3,132,153 | |
| 3,103,049 | |
| 3,155,162 | |
| 3,197,419 | |
| -713,079 | |
| -467,044 | |
| -284,662 | |
| -46,226 | |
| -149,079 | |
| -673,447 | |
| -915,772 | |
| -909,871 | |
| -806,083 | |
| -256,083 | |
| -6,083 | |
| -6,473 | |
| -6,500 | |
| -12,443 | |
| -12,443 | |
| -10,664 | |
| -5,943 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -3,831 | |
| -3,831 | |
| -3,831 | |
| -3,831 | |
| 0 | |
| 0 | |
| -3,639 | |
| -5,116 | |
| -5,116 |